Home » Investing
Profound Medical (NASDAQ:PROF) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen downgraded shares of Profound Medical (NASDAQ:PROF – Free Report) from a hold rating to a sell rating in a report released on Saturday morning,Wall Street Zen reports. PROF has been the topic of several other... More of this article »
Twin Disc (NASDAQ:TWIN) Upgraded by Wall Street Zen to Strong-Buy Rating
Wall Street Zen upgraded shares of Twin Disc (NASDAQ:TWIN – Free Report) from a buy rating to a strong-buy rating in a report published on Saturday,Wall Street Zen reports. A number of other brokerages have also issued reports... More of this article »
Biosig Technologies (NASDAQ:STEX) Upgraded to “Hold” at Wall Street Zen
Wall Street Zen upgraded shares of Biosig Technologies (NASDAQ:STEX – Free Report) from a sell rating to a hold rating in a report released on Saturday morning,Wall Street Zen reports. A number of other equities analysts also... More of this article »
NVE (NASDAQ:NVEC) Downgraded to “Hold” Rating by Wall Street Zen
Wall Street Zen cut shares of NVE (NASDAQ:NVEC – Free Report) from a buy rating to a hold rating in a research report report published on Saturday morning,Wall Street Zen reports. Separately, Weiss Ratings raised shares of NVE... More of this article »
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Upgraded by Wall Street Zen to Sell Rating
Wall Street Zen upgraded shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) from a strong sell rating to a sell rating in a research note published on Saturday morning,Wall Street Zen reports. A number of other research... More of this article »
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $920.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective hoisted by HSBC from $800.00 to $920.00 in a research note released on Thursday morning,Benzinga reports. HSBC currently has a buy rating on the biopharmaceutical... More of this article »
Matador Resources (NYSE:MTDR) Research Coverage Started at Stifel Nicolaus
Stifel Nicolaus began coverage on shares of Matador Resources (NYSE:MTDR – Free Report) in a report released on Thursday. The firm issued a buy rating and a $66.00 target price on the energy company’s stock. MTDR has been... More of this article »
Rep. Gilbert Ray Cisneros, Jr. Unloads Shares of NIKE, Inc. (NYSE:NKE)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of NIKE, Inc. (NYSE:NKE). In a filing disclosed on September 10th, the Representative disclosed that they had sold between $15,001 and $50,000 in... More of this article »
CTS (NYSE:CTS) Research Coverage Started at Barrington Research
Barrington Research initiated coverage on shares of CTS (NYSE:CTS – Free Report) in a report released on Thursday morning, Marketbeat Ratings reports. The firm issued an outperform rating and a $80.00 target price on the electronics... More of this article »
Lamar Advertising (NASDAQ:LAMR) Stock Sold Off Rep. Gilbert Ray Cisneros, Jr.
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Lamar Advertising Company (NASDAQ:LAMR). In a filing disclosed on September 10th, the Representative disclosed that they had sold between $15,001... More of this article »
Occidental Petroleum (NYSE:OXY) Research Coverage Started at Stifel Nicolaus
Stifel Nicolaus assumed coverage on shares of Occidental Petroleum (NYSE:OXY – Free Report) in a research report released on Thursday morning. The firm issued a hold rating and a $68.00 price objective on the oil and gas producer’s... More of this article »
United Rentals’ (URI) Neutral Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. reissued their neutral rating on shares of United Rentals (NYSE:URI – Free Report) in a research note issued to investors on Thursday, Marketbeat reports. JPMorgan Chase & Co. currently has a $1,170.00... More of this article »
Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Target Price at $14.00
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has received an average recommendation of “Hold” from the nine research firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts... More of this article »
Flowco Holdings Inc. (NYSE:FLOC) Receives $28.40 Consensus Price Target from Analysts
Shares of Flowco Holdings Inc. (NYSE:FLOC – Get Free Report) have earned an average rating of “Hold” from the seven research firms that are presently covering the stock, MarketBeat Ratings reports. One equities research... More of this article »
Rosenblatt Securities Cuts Chewy (NYSE:CHWY) Price Target to $24.00
Chewy (NYSE:CHWY – Free Report) had its price objective decreased by Rosenblatt Securities from $25.00 to $24.00 in a report released on Thursday,Benzinga reports. Rosenblatt Securities currently has a neutral rating on the stock. A... More of this article »
Mission Produce’s (AVO) Buy Rating Reiterated at Roth Capital
Roth Capital reiterated their buy rating on shares of Mission Produce (NASDAQ:AVO – Free Report) in a report published on Thursday,Benzinga reports. Roth Capital currently has a $17.00 price objective on the stock. AVO has been... More of this article »
Coastal Financial Corporation (NASDAQ:CCB) Receives $91.33 Consensus Target Price from Brokerages
Coastal Financial Corporation (NASDAQ:CCB – Get Free Report) has received an average rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research... More of this article »
Editas Medicine, Inc. (NASDAQ:EDIT) Receives $6.00 Average Target Price from Analysts
Shares of Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) have received an average rating of “Moderate Buy” from the five research firms that are currently covering the firm, Marketbeat.com reports. One investment... More of this article »
JPMorgan Chase & Co. Cuts Vinci Compass Investments (NASDAQ:VINP) Price Target to $14.00
Vinci Compass Investments (NASDAQ:VINP – Free Report) had its price target reduced by JPMorgan Chase & Co. from $15.00 to $14.00 in a research report released on Thursday,Benzinga reports. They currently have an overweight... More of this article »
Qorvo (NASDAQ:QRVO) Reaches New 1-Year High – Here’s Why
Qorvo, Inc. (NASDAQ:QRVO – Get Free Report)’s stock price hit a new 52-week high during trading on Friday . The company traded as high as $114.28 and last traded at $112.36, with a volume of 2254209 shares changing hands.... More of this article »
DNOW (NYSE:DNOW) Cut to Hold at Freedom Broker
Freedom Broker cut shares of DNOW (NYSE:DNOW – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday, Marketbeat Ratings reports. Freedom Broker currently has $18.00 price target on... More of this article »
Seaport Therapeutics’ (SPTX) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Seaport Therapeutics (NASDAQ:SPTX – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $50.00 target price... More of this article »
Apple’s (AAPL) “Neutral” Rating Reiterated at Rosenblatt Securities
Rosenblatt Securities reissued their neutral rating on shares of Apple (NASDAQ:AAPL – Free Report) in a research report report published on Thursday morning,Benzinga reports. Rosenblatt Securities currently has a $303.00 price... More of this article »
Mach Natural Resources (NYSE:MNR) Research Coverage Started at Stifel Nicolaus
Stifel Nicolaus started coverage on shares of Mach Natural Resources (NYSE:MNR – Free Report) in a research report report published on Thursday morning, MarketBeat reports. The brokerage issued a buy rating and a $15.00 price... More of this article »
Amer Sports (NYSE:AS) Research Coverage Started at BTIG Research
BTIG Research began coverage on shares of Amer Sports (NYSE:AS – Free Report) in a research note released on Thursday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $42.00 target price on the stock. A... More of this article »
BlossomHill Therapeutics, Inc.’s (NASDAQ:BLSM) Quiet Period To End on September 16th
BlossomHill Therapeutics’ (NASDAQ:BLSM – Get Free Report) quiet period is set to expire on Wednesday, September 16th. BlossomHill Therapeutics had issued 9,375,000 shares in its public offering on August 7th. The total... More of this article »
National Bank Financial Analysts Give Loblaw Companies (TSE:L) a C$70.00 Price Target
National Bank Financial set a C$70.00 target price on Loblaw Companies (TSE:L – Free Report) in a report released on Thursday morning,BayStreet reports. The firm currently has an outperform rating on the stock. A number of other... More of this article »
Serina Therapeutics’ (SER) “Buy” Rating Reiterated at BTIG Research
BTIG Research reaffirmed their buy rating on shares of Serina Therapeutics (NYSEAMERICAN:SER – Free Report) in a research report released on Thursday,Benzinga reports. The firm currently has a $8.00 target price on the stock. Serina... More of this article »
Genus’ (GNS) “Buy” Rating Reiterated at Berenberg Bank
Berenberg Bank reaffirmed their buy rating on shares of Genus (LON:GNS – Free Report) in a research report released on Thursday morning,Digital Look reports. The brokerage currently has a GBX 3,350 target price on the stock. Genus... More of this article »
Troilus Gold (CVE:TLG) Price Target Raised to C$4.80
Troilus Gold (CVE:TLG – Free Report) had its price target increased by ATB Cormark Capital Markets from C$4.00 to C$4.80 in a report issued on Thursday morning,BayStreet reports. The brokerage currently has a top pick rating... More of this article »
NanoXplore (NNXPF) to Release Earnings on Tuesday
NanoXplore (OTCMKTS:NNXPF – Get Free Report) is expected to be posting its results after the market closes on Tuesday, September 15th. Analysts expect NanoXplore to post earnings of ($0.0099) per share and revenue of $24.1910... More of this article »
Insider Buying: Crest Nicholson (LON:CRST) Insider Acquires £150.45 in Stock
Crest Nicholson Holdings plc (LON:CRST – Get Free Report) insider William Floydd bought 255 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The stock was purchased at an average... More of this article »
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months
OPKO Health (NASDAQ:OPK) outlined a strategy to shift its business mix toward therapeutics while continuing to streamline its diagnostics operations, with management highlighting a pipeline of early-stage clinical programs, external... More of this article »
Comparing Lendingclub (NASDAQ:HAPN) & Vroom (NASDAQ:VRM)
Vroom (NASDAQ:VRM – Get Free Report) and Lendingclub (NASDAQ:HAPN – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their... More of this article »
Financial Contrast: Heartflow (NASDAQ:HTFL) versus Aclarion (NASDAQ:ACON)
Heartflow (NASDAQ:HTFL – Get Free Report) and Aclarion (NASDAQ:ACON – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their... More of this article »
Head to Head Review: Zumiez (NASDAQ:ZUMZ) and 1-800 FLOWERS.COM (NASDAQ:FLWS)
1-800 FLOWERS.COM (NASDAQ:FLWS – Get Free Report) and Zumiez (NASDAQ:ZUMZ – Get Free Report) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two companies based on... More of this article »
Critical Contrast: Aura Minerals (AUGO) & The Competition
Aura Minerals (NASDAQ:AUGO – Get Free Report) is one of 1,987 publicly-traded companies in the “Metals & Mining” industry, but how does it contrast to its rivals? We will compare Aura Minerals to related businesses... More of this article »
Asahi Glass (OTCMKTS:ASGLY) vs. Intrepid Potash (NYSE:IPI) Head-To-Head Comparison
Asahi Glass (OTCMKTS:ASGLY – Get Free Report) and Intrepid Potash (NYSE:IPI – Get Free Report) are both materials companies, but which is the superior business? We will compare the two businesses based on the strength of... More of this article »
Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Globus Medical, Inc. (NYSE:GMED)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Globus Medical, Inc. (NYSE:GMED). In a filing disclosed on September 10th, the Representative disclosed that they had bought between $15,001... More of this article »
Rep. Gilbert Ray Cisneros, Jr. Sells Off AppLovin Corporation (NASDAQ:APP) Shares
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of AppLovin Corporation (NASDAQ:APP). In a filing disclosed on September 10th, the Representative disclosed that they had sold between $1,001 and... More of this article »
Sen. Cory A. Booker Unloads Shares of Netflix, Inc. (NASDAQ:NFLX)
Senator Cory A. Booker (Democratic-New Jersey) recently sold shares of Netflix, Inc. (NASDAQ:NFLX). In a filing disclosed on September 09th, the Senator disclosed that they had sold between $1,001 and $15,000 in Netflix stock on August... More of this article »
Rep. Gilbert Ray Cisneros, Jr. Sells Shares of NVIDIA Corporation (NASDAQ:NVDA)
Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of NVIDIA Corporation (NASDAQ:NVDA). In a filing disclosed on September 10th, the Representative disclosed that they had sold between $1,001 and... More of this article »
Fortinet Sees AI, Neocloud Buildout Fueling Network Security Demand
Fortinet (NASDAQ:FTNT) executives said the cybersecurity company sees artificial intelligence as a growing source of demand for network security, particularly as enterprises and emerging “neocloud” providers build AI infrastructure... More of this article »
Lattice Semiconductor (NASDAQ:LSCC) & Magnachip Semiconductor (NYSE:MX) Critical Comparison
Magnachip Semiconductor (NYSE:MX – Get Free Report) and Lattice Semiconductor (NASDAQ:LSCC – Get Free Report) are both technology companies, but which is the superior stock? We will contrast the two businesses based on... More of this article »
Head to Head Contrast: Genmab A/S (NASDAQ:GMAB) and Spyre Therapeutics (NASDAQ:SYRE)
Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) and Genmab A/S (NASDAQ:GMAB – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength... More of this article »
Head-To-Head Survey: Vireo Growth (OTCMKTS:VREOD) versus Alpha Cognition (NASDAQ:ACOG)
Alpha Cognition (NASDAQ:ACOG – Get Free Report) and Vireo Growth (OTCMKTS:VREOD – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on... More of this article »
Head to Head Review: Nano-X Imaging (NASDAQ:NNOX) versus Stryker (NYSE:SYK)
Stryker (NYSE:SYK – Get Free Report) and Nano-X Imaging (NASDAQ:NNOX – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their... More of this article »
Head-To-Head Review: Generate Biomedicines (GENB) & The Competition
Generate Biomedicines (NASDAQ:GENB – Get Free Report) is one of 857 public companies in the “Biotechnology” industry, but how does it compare to its competitors? We will compare Generate Biomedicines to similar companies... More of this article »